Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

VK launched an open beta test of generative neural networks

4/11/24 VKCO

Board of Directors of RosDorBank recommended dividends

4/11/24 RDRB

Severstal restores electric steel production volume

4/11/24 CHMF

Fesco launches scheduled flights from Vietnam to Russia

4/11/24 FESH

Novatek's gas sales volume in Q1 decreased by 3.8%

4/11/24 NVTK

Angara-A5 launched from Vostochny Cosmodrome

4/11/24 RKKE

EuroTrans opened the first window of acceptance of the OTC offer

4/11/24 EUTR

Yandex wants to install Yandex Auto on Chinese cars

4/11/24 YNDX

Yandex testing service for cloud gaming

4/11/24 YNDX

Softline completed an additional exchange of Noventiq receipts

4/11/24 SOFL